Login to Your Account



NewCo News

AlphaCore Aiming High with Recombinant LCAT

By Marie Powers
Staff Writer

Thursday, January 3, 2013

AlphaCore Pharma Inc. has maintained a low profile since its founding in 2007, perhaps befitting for a biotech working in the rare orphan indication of familial LCAT deficiency (FLD).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription